Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Cardiff Oncology (CRDF) Gross Profit (2016 - 2019)

Cardiff Oncology (CRDF) has disclosed Gross Profit for 7 consecutive years, with $92577.0 as the latest value for Q4 2019.

  • Quarterly Gross Profit rose 18.67% to $92577.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $243137.0 through Dec 2019, up 190.66% year-over-year, with the annual reading at $244632.0 for FY2019, 211.64% up from the prior year.
  • Gross Profit hit $92577.0 in Q4 2019 for Cardiff Oncology, up from $51687.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $92577.0 in Q4 2019 to a low of -$5.9 million in Q4 2015.
  • Historically, Gross Profit has averaged -$440559.3 across 5 years, with a median of -$152404.0 in 2015.
  • Biggest five-year swings in Gross Profit: tumbled 14731.98% in 2015 and later soared 139.79% in 2019.
  • Year by year, Gross Profit stood at -$5.9 million in 2015, then soared by 91.25% to -$519219.0 in 2016, then skyrocketed by 61.75% to -$198593.0 in 2017, then surged by 139.28% to $78015.0 in 2018, then increased by 18.67% to $92577.0 in 2019.
  • Business Quant data shows Gross Profit for CRDF at $92577.0 in Q4 2019, $51687.0 in Q3 2019, and $36852.0 in Q2 2019.